NCT00572117View on ClinicalTrials.gov

Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Bipolar DisorderAlcoholismAlcohol Dependence
Interventions
DRUG

Topiramate

Medication will be slowly increased over 5 weeks from 25 mg a day to 150 mg twice a day in an effort to minimize side effects that might enable participants and raters to guess whether they are on active drug or placebo. Subjects will continue on 150 mg twice a for Weeks 6-12 of the study.

Trial Locations (1)

94304

Stanford/VA Palo Alto Mood Disorder Research Program, Palo Alto

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Stanford University

OTHER

NCT00572117 - Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder | Biotech Hunter | Biotech Hunter